Nexalin Technology (NXL) Shares Outstanding (Diluted Average) (2022 - 2026)

Nexalin Technology (NXL) recorded quarterly Shares Outstanding (Diluted Average) of $19.8 million in Q1 2026, up 20.91% quarter-over-quarter from $16.4 million in Q4 2025, and up 48.95% on a YoY basis from $13.3 million in Q1 2025.

Nexalin Technology (NXL) Shares Outstanding (Diluted Average) (2022 - 2026) Analysis & Trends

Nexalin Technology's Shares Outstanding (Diluted Average) history runs 5 years deep, the most recent figure standing at $19.8 million for Q1 2026.

  • In Q1 2026, Shares Outstanding (Diluted Average) rose 48.95% year-over-year to $19.8 million; the TTM figure through Mar 2026 stood at $19.8 million (up 48.95% YoY), while the FY2025 annual figure was $16.4 million, up 77.87% from the prior year.
  • Shares Outstanding (Diluted Average) was $19.8 million for Q1 2026 at Nexalin Technology, up from $16.4 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $19.8 million in Q1 2026 to a low of $4.9 million in Q2 2022.
  • Historically, Shares Outstanding (Diluted Average) has averaged $9.8 million across 5 years, with a median of $7.5 million in 2024.
  • The sharpest annual moves came in 2024 and 2025: Shares Outstanding (Diluted Average) gained 2.06% in 2024, then soared 93.75% in 2025.
  • A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $5.6 million in 2022, then soared by 32.03% to $7.4 million in 2023, then gained by 25.26% to $9.2 million in 2024, then jumped by 77.87% to $16.4 million in 2025, then grew by 20.91% to $19.8 million in 2026.
  • The last three Shares Outstanding (Diluted Average) figures came in at $19.8 million (Q1 2026), $16.4 million (Q4 2025), and $15.6 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Diluted Avg.) (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 1.75 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 386.50 Mn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 1.29 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 1.50 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 580.70 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 393.60 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 457.00 Mn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn -
10 Nexalin Technology 7.82 Mn 5.11 Mn 13,133.00 19.82 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 19.82 Mn
Dec 31, 2025 16.39 Mn
Sep 30, 2025 15.63 Mn
Jun 30, 2025 14.53 Mn
Mar 31, 2025 13.31 Mn
Dec 31, 2024 9.22 Mn
Sep 30, 2024 8.61 Mn
Jun 30, 2024 7.50 Mn
Mar 31, 2024 7.44 Mn
Dec 31, 2023 7.36 Mn
Sep 30, 2023 7.42 Mn
Jun 30, 2023 7.29 Mn
Mar 31, 2023 7.29 Mn
Dec 31, 2022 5.57 Mn
Sep 30, 2022 5.19 Mn
Jun 30, 2022 4.90 Mn